Stem cell tourism “an emerging public health threat”


In an article on the survey results, published in Multiple Sclerosis News Today, report author Wijden Raj, from The Ohio State University calls for the creation of a publicly available national registry where ‘stem cell tourism’ complications must be reported, and the development of guidelines "on how to care for patients who have undergone experimental stem cell procedures with tumor formation".

Raj said that "75% of the physicians indicated that no patient experienced complications" from unapproved stem-cell-based treatments. However, one in four (25%) reported seeing patients who experienced complications, such as infections, MS deterioration and relapse, stroke, meningoencephalitis, sepsis, tumors, hepatitis C, seizures, or spinal cord injury. At least three neurologists had patients who died from unapproved stem cell procedures.

Stem cell tourism is an "emerging public health threat," and the results "demonstrate an alarming number of unreported complications and negative impact to MS patients," Raj said.



Do you have some news or a press release that you’d like to share with the medical travel industry?

Publish for FREE on IMTJ.


Related News

US stem cell crack down

06 June, 2019

FDA puts pressure on US stem cell clinics

Caymans niche clinics

28 May, 2019

Potential in small clinics for Caymans

China medical tourism pilot zone

12 May, 2019

New hospital for China’s Boao Lechang project

US stem cell clinic lawsuit

29 April, 2019

Clinic accused of mis-selling unproven treatments

Saudi medical travellers warning

25 March, 2019

Doctors warn Saudis about fake medical centres abroad